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A b s t r a c t
Introduction: The main limitation of coronary artery bypass grafting (CABG) is rapid neointimal hyperplasia leading to graft 
failure.
Aim: To assess plaque formation in saphenous vein grafts (SVG) covered by an external Dacron stent in comparison with the 
classical technique.
Material and methods: In the study group vein grafts covered by external stent mesh made of Dacron were implanted. An 
intravascular ultrasonography (IVUS) study was performed in 35 aorto-coronary SVG covered by an external Dacron stent and in 
64 normal SVG during the first year after CABG. In each SVG 25 mm of good quality IVUS image, volumes of lumen, plaque (neoin-
tima), outer border of the vein graft (external SVG) and adventitia were calculated in three time periods: 0–130 days, 130–260 days 
and 260–390 days.
Results: Between the first and second time period, lumen volume (mm3) was reduced from 10.33 ±4.4, to 6.80 ±2.23 in the 
second period and 5.69 ±1.26 in the third one. This effect was much less marked in normal grafts. The corresponding lumen volume 
(mm3) was: 10.90 ±3.9, 9.15 ±2.94 and 8.92 ±2.93 in consecutive time periods. Plaque volume (mm3) did not change in control grafts 
during the course of the study, but it increased very significantly in stented grafts from 0.86 ±1.24 in the first period to 2.70 ±1.58 
in the second and 3.29 ±2.66 in the third one.
Conclusions: The experimental technique of implanting SVG covered with an external elastic Dacron stent seems to be inferior 
to traditional ones. This is probably due to the more complicated process of vein implantation and higher micro-injury occurrence 
during the surgery.
Key words: coronary artery bypass grafting, intravascular ultrasonography, neointima.
Introduction
The crucial limitation of coronary artery bypass 
grafting (CABG), when the saphenous vein is used as 
a conduit, is poor long-term vein graft patency [1]. Five-
year failure rates are 30–50% and have remained un-
changed despite rapid development of pharmacological 
treatments and technologies. This has a significant ef-
fect on patient health and an important influence on 
the cost of treatment also. The main reason for vein 
graft occlusion, especially in the mid-term, is neointimal 
hyperplasia (NIH) [2]. Various treatments have been in-
vestigated with a view to reducing NIH [3–5]. One such 
method is the use of synthetic external supports for 
vein grafts [6].
Several studies suggest that the application of an 
external stent around the grafted vein delays neointi-
ma formation and increases patency [7]. We therefore 
assessed the effect on saphenous vein graft patency of 
an external, fine network stent made of Torlen/Dacron 
fibres [8]. 
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Material and methods
Patients
The study was approved by the local Ethical Commit-
tee of the Silesian University in Katowice (approval num-
ber: L.dz.NN-013-267/01). All patients provided informed 
consent. A total of 105 (40 in the study group and 65 in 
the control group) patients with stable angina were en-
rolled in this study. The decision whether to proceed with 
patient enrolment was made by the heart team (cardiol-
ogist and cardiac surgeon). Twenty-four patients refused 
to participate in follow-up examinations after CABG 
(4 from the study group, 20 from the control group) 
with 4 (1 from the study group, 3 from the control group) 
excluded because they moved away from the area. In 
5 patients in the study group and 5 in the control group, 
intravascular ultrasonography (IVUS) was not performed 
because of severe graft stenosis. Thirteen patients 
(8 from the study group and 5 from the control group) 
were not included in these analyses because of time 
limitations. Therefore this study and analysis includes 
32 patients enrolled in the control group and 22 patients 
in the study group. 
The study inclusion criteria were: men and women, 
age 40–65 years, with multi-vessel coronary disease, 
critical stenosis in the right coronary artery (RCA), stable 
angina, systolic blood pressure (BP) below 160 mm Hg, 
blood glucose below 7.8 mmol/l. The exclusion criteria 
were: lack of written consent, inability to perform full ar-
terial revascularisation, varicose veins, saphenous vein of 
poor quality, unstable angina, low ejection fraction (left 
ventricular ejection fraction (LV EF) < 30%), concomitant 
valve disease, critical stenosis of the carotid arteries, Ler-
iche syndrome, and any other condition which limited life 
expectancy to less than 2 years. 
The primary aim of the study was to use IVUS to de-
termine the usefulness of this modified cardio-surgery 
technique in clinical practice.
The secondary endpoints were the occurrence of 
major adverse cardiac events (MACE) or major adverse 
cardiac and cerebrovascular events (MACCE), and the re-
quirement for repeat revascularisation procedures. Sec-
ondary endpoints were assessed in the first year after 
operation and in long-term follow-up, between 7 and 
14 years after CABG. 
We compared coronary and IVUS procedures in three 
time periods: the first was 0 to 130 days after grafting, 
the second was 130 to 260 days after grafting, and the 
third was 260 to 390 days after grafting. Patient details 
are given in Table I.
External Dacron stent construction 
In collaboration with Tricomed S.A., Lodz, Poland, 
a 4 mm diameter mesh made out of polyester fibre (Tor-
len/Dacron) was constructed (Figure 1). This stent con-
sists of empty rhomboidal spaces created by single inter-
lacing of Torlen threads and provides external support to 
the native vein. This extravascular stent is very resistant 
to bending and has an ability to change its diameter de-
pending on forces acting along its long axis.
The CABG procedure was performed with general 
anaesthesia, with medial sternotomy access, extracor-
poreal circulation and moderate hypothermia (32°C). All 
Table I. Baseline characteristics of patients included in the study
Parameter Study group (n = 40) Control group (n = 65) P-value
Age [years] 55.4 ±10.16 54.72 ±8.84 0.41
Ejection fraction (%) 54.64 ±6.21 54.23 ±6.2 0.72
History of MI prior to CABG 14 (35%) 22 (34%) 0.42
History of PCI prior to CABG 5 (12.5%) 11 (16.9%) 0.37
Hypertension 26 (65%) 41 (63%) 0.77
Hypercholesterolaemia 32 (80%) 49 (75.4%) 0.52
Total cholesterol [mg/dl] 209 ±38.3 207 ±46.62 0.47
LDL cholesterol [mg/dl] 130 ±40.22 127 ±76.36 0.46
HDL cholesterol [mg/dl] 43 ±8.08 44 ±11.62 0.43
Triglyceride [mg/dl] 155 ±78.04 145 ±72.58 0.16
Creatinine [mg/dl] 1.03 ±0.13 0.97 ±0.15 0.39
Current smoker 12 (30%) 19 (29.3%) 0.41
History of smoking 17 (42.5%) 26 (40%) 0.43
Non-smoker 11 (27.5%) 20 (30.7%) 0.42
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patients received left internal mammary artery grafts 
implanted into the left anterior descending artery and 
saphenous vein grafts to other coronary vessels. In the 
study group a 15 cm segment of vein graft was fed inside 
the Dacron stent and fused to it with tissue glue (Tissu-
col). The proximal and distal parts of the graft were not 
covered by the stent. 
Coronary angiography and intravascular 
ultrasonography
Coronary angiography was performed after access via 
the femoral artery. All patients underwent angiography of 
the native coronary vessels and then selective angiogra-
phy of the venous bypass grafts. The IVUS examinations 
were performed using the Volcano system, with stan-
dard 20 MHz ultrasonographic probes moved by a pull-
back device at a speed of 1 mm/s. The examination was 
preceded by the direct application to the grafted vein of 
5000 IU of heparin and 0.2 mg of nitroglycerine. Analy-
sis was carried out using QCU-CMS IVUS analytical soft-
ware, version 4.14. A 25 mm section was analysed. The 
analysed data consisted of 250 single ultrasonographic 
images created during the examination (10 images per 
millimetre). Mean volumetric parameters were calculat-
ed for a 1 mm length of saphenous vein grafts (SVG).
The selection of the venous bypass graft section was 
made on the basis of the quality of the image, includ-
ing the area of the bypass graft with the most advanced 
neointima formation. Sections adjacent to the proximal 
and distal part of the bypass graft were excluded from 
the analysis.
Analysis of IVUS records gave the following data: lu-
men volume, external elastic membrane (EEM) volume 
and volume of the outer border of the vein graft (external 
SVG). Adventitia volume was calculated as the difference 
between the volume of the outer border of the SVG and 
the EEM volume. The external elastic membrane in arte-
rial vessels is measured as the external border of a hy-
poechogenic zone which represents the media [9, 10]. 
In arteries this zone is usually easily visible. In contrast, 
saphenous vein grafts are much more difficult to assess. 
Remodelling processes, proliferation, migration of myo-
fibroblasts and production of external extracellular sub-
stances involve the whole diameter of the bypass. Ad-
ventitia and media invasion by adipose tissue can make 
the EEM membrane difficult to see even under the mi-
croscope [11].
All images with an unequivocally visible echo-negative 
border were assumed to represent the media (Figure 2). 
Data acquisition and analysis
Coronary angiographic and IVUS procedures were 
performed in the control group between 4 and 506 days 
after CABG, and in the study group between 6 and 523 
days. Some patients (19 vein grafts in the control group 
Figure 1. Stent ex-vivo and stented graft in-vivo (black arrow), regular graft (white arrow)
Figure 2. Delineation of the neointima (red line) 
and the external elastic membrane (green line) in 
a saphenous vein bypass graft ultrasonogram
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and 13 vein grafts with external stents) had a  second 
IVUS procedure. A total of 64 IVUS examinations in un-
stented vein bypass grafts, and 35 IVUS examinations in 
vein grafts with the external Dacron stent, were analysed 
in the three time periods. 
Statistical analysis
Results are expressed as mean ± standard deviation. 
Comparisons between groups were made using Student’s 
unpaired two-tailed t-test, having checked for equiva-
lence of variance by means of an F test. Differences with 
p < 0.05 were considered to be statistically significant.
Results
Patient details are given in Table I. Comparisons 
between patients in the two groups were made using 
non-parametric methods, and no statistically significant 
differences were found. 
Table II shows data concerning the number of occlud-
ed vein grafts in each group. In analysis of selected risk 
factors for SVG occlusion in the control and study group, 
smoking was determined as a significant risk factor for 
saphenous vein graft occlusion. 
During the first year of follow-up, no deaths, myocardi-
al infarctions, MACE or MACCE were observed. The average 
hospitalization time was 7 ±4 days in the study group and 
6.4 ±1.3 days in the control group. Because of post-opera-
tive wound infection and sternum restabilization, 1 patient 
from the study group left hospital after 29 days of hos-
pitalization. One patient from the control group suffered 
an acute coronary event 20 days after CABG, requiring ur-
gent percutaneous coronary intervention (PCI). In 9 others 
(5 from the study group, 4 from the control group) signifi-
cant stenosis or SVG occlusion was noted.
As summarised in Table III, there were no significant 
differences between control and stented saphenous vein 
grafts in terms of the analysed parameters at the time of 
the first IVUS examination, 0–130 days after graft em-
placement. There was a  gradual and significant reduc-
tion in lumen volume in unstented grafts over the course 
of the study, but this effect was much more marked in 
grafts covered with the external stent. The control lumen 
volume was reduced by 18.2%, but in stented grafts it fell 
by 44.9% (p < 0.05).
Neointima (plaque) volume did not change in control 
grafts during the course of the study, but it increased very 
significantly in stented grafts. By the end of the study, 
neointima volumes in stented grafts were increased 3.8–
fold (p < 0.05) (Figure 3).
There was no significant change in adventitia volume 
in the control group between the first and second time 
periods; in contrast, in the study group there was a sig-
nificant reduction in adventitia volume during the same 
interval. Similarly, a  significant reduction in adventitial 
volume was observed in the external stent group. 
Table II. Angiography characteristics of sapheno-
us vein grafts
Vein grafts  
(analysed by angiography)
Control group Study group
Number of saphenous vein 
grafts performed/patent  
(% of patent grafts):
105/95 (90.5) 47/37 (78.7)
0 to 130 days 36/34 (94.4) 26/21 (80.8)
130 to 260 days 34/29 (85.3) 11/8 (72.7)
260 to 390 days 35/32 (91.4) 10/8 (80.0)
Table III. Summary of IVUS analysis
Time interval Compartment volume Control
(mean ± SD)
External stent
(mean ± SD)
0 to 130 days Lumen [mm3] 10.90 ±3.9 10.33 ±4.4
Plaque [mm3] 1.59 ±2.21 0.86 ±1.24
Adventitia [mm3] 8.61 ±2.26 7.98 ±1.89
SVG vessel [mm3] 21.1 ±5.04 19.23 ±5.49
130 to 260 days Lumen [mm3] 9.15 ±2.94 6.80 ±2.23*
Plaque [mm3] 1.02 ±2.10 2.70 ±1.58*
Adventitia [mm3] 10.36 ±3.62 5.50 ±2.02*
SVG vessel [mm3] 20.54 ±6.16 15.13 ±4.14*
260 to 390 days Lumen [mm3] 8.92 ±2.93 5.69 ±1.26*
Plaque [mm3] 1.36 ±1.73 3.29 ±2.66*
Adventitia [mm3] 9.47 ±2.67 6.46 ±2.55*
SVG vessel [mm3] 19.74 ±5.10 15.44 ±4.85*
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Discussion
Despite the limitations of CABG, as well as the contin-
ued development of interventional cardiological methods, 
this technique has a continuing role in the treatment of 
left main and multi-vessel coronary artery disease. Rapid 
neointimal hyperplasia, leading to graft failure, is one of 
the main causes of CABG failure. Potential solutions have 
been investigated using both pharmacological and inter-
ventional approaches [3, 4]. In 1978 the beneficial effect 
of an external polyester stent was described by Karayan-
nacos et al. [12]. This effect is explained by three main the-
ories: positive effects on haemodynamics [13], increased 
adventitial angiogenesis with the promotion of vasa va-
sorum around the vein graft [14, 15], and accumulation of 
immune and inflammatory cells within the mesh [7].
However, the clinical benefit of this technique is not 
known. In this study we used IVUS for precise evaluation 
of vein graft responses to external stenting. The IVUS 
is a  powerful tool for investigating native and grafted 
vessels, allowing measurement of such parameters as 
lumen area, wall thickness, plaque area and so on [16]. 
It enables a very precise longitudinal analysis of plaque 
development and the adaptive mechanisms taking place 
in the vessel [16–19], and indeed IVUS examinations of 
bypass grafts show a strong correlation with histological 
measurements [20]. 
Grafts implanted in the control group showed a grad-
ual loss of lumen over time, but neointima volume did 
not change significantly during the same period. This 
suggests that neointimal thickening is unlikely to be the 
causative factor for loss of lumen. 
The potentially favourable reduction in adventitia vol-
ume in the stented group is completely counteracted by 
a  very intense process of neointima formation. Conse-
quently there was a marked reduction in lumen volume 
in stented vessels, possibly leading to occlusion in some 
of them.
Similar results to the present material were reported 
by Violaris et al. in 1993. That paper showed that a possi-
ble positive effect on the external tunica was completely 
compensated by very significant development of neointi-
ma in stented bypasses [21].
The reduction in adventitia volume is difficult to ex-
plain. One possible factor is the accumulation of inflam-
matory cells in the space between the external stent and 
the vascular wall [7, 22]. These cells produce a number of 
factors which are specific chemoattractants for adven-
titial fibroblasts, which could lead to migration of cells 
from the adventitia of the venous bypass towards the 
external stent.
At the same time, matrix production by adventitial fi-
broblasts could occur within the space between the stent 
and the wall. Taking into account this mechanism, which 
is responsible for the reduction in adventitial volume, one 
cannot exclude a negative effect on the stented bypass 
that could lead to a significant decrease in the luminal 
volume of the transplanted vein.
In stented bypasses the total volume of the venous 
bypass wall did not change significantly between time 
intervals I  and II. It should be emphasized that during 
this period the stented vessel undergoes reconstruction: 
there is a reduction in the total volume of the vein, a sta-
tistically significant increase in neointima volume, and 
compensating for this a decrease in adventitial volume.
Histological examinations suggest that different seg-
ments of venous bypasses react in specific ways, related 
to the varying local haemodynamic conditions and the 
morphology of the vein [23, 24]. The development of 
neointima at the site of anastomosis seems to be con-
nected with vessel narrowing and turbulent blood flow 
[25, 26], whereas in the middle segment the condition 
of the vein, previously occurring disorders and surgical 
technique are more important [27]. In this context it is 
important to note that the preparation of the vein for 
grafting, and in particular the process of putting the ex-
Figure 3. Lumen volume and neointima (plaque) volume as determined by IVUS in control and stented saphenous 
vein grafts. Values are normalised to the measurement at the earliest time point. Bars show mean values with 
associated standard deviations; dark bars are control grafts, light bars are externally stented grafts (*p < 0.05)
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ternal Dacron stent over the graft, may have caused extra 
damage leading to an exaggerated response.
This study has several limitations which could poten-
tially influence the results. There was a  relatively small 
number of enrolled patients; vein grafts were analysed 
over a range of different time periods; and the IVUS anal-
ysis was limited to only 25 mm of vein graft. Further-
more, the proximal and distal parts of the graft were not 
covered by the stent, so we cannot predict the influence 
of the stent on distal and proximal anastomoses.
Conclusions
In this study we observed a  significant process of 
neointima formation over time in stented saphenous 
vein grafts. This technique should not be translated into 
routine clinical practice at this time. 
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